On March 7, 2024 a meeting was hosted by the CDC that consisted of a small group of expert-advocates to develop the CDC’s understanding of the lived experience of Lyme disease. The goal of this meeting was to compile a list of individual questions to understand more about a future Lyme disease vaccine, and the VLA15 vaccine in particular, given it was the only vaccine candidate being evaluated in phase 3 clinical trials as of the date of this meeting. Pat Smith reported on this meeting in the President’s Blog – In-depth Synopsis of Advocate Vaccine Meeting Hosted by CDC. The following is a list of all the questions contributed by the participants of the meeting. These questions were shared with a Pfizer representative by the CDC on March 8, 2024. As of April 30, 2024, there has been no response by Pfizer.
Lyme Disease Vaccine Technical Consultation, March 7-8, 2024Meeting Product
On March 7, 2024 a small …